Glial Cell Activation and Oxidative Stress in Retinal Degeneration Induced by β-Alanine Caused Taurine Depletion and Light Exposure.
Animals
Cell Count
Cell Survival
Female
Glial Fibrillary Acidic Protein
/ metabolism
Light
Microglia
/ pathology
Neuroglia
/ metabolism
Oxidative Stress
/ radiation effects
Photoreceptor Cells, Vertebrate
/ pathology
Rats, Sprague-Dawley
Retinal Degeneration
/ blood
Retinal Pigment Epithelium
/ diagnostic imaging
Synapses
/ metabolism
Taurine
/ blood
Tomography, Optical Coherence
beta-Alanine
Müller cells
microglia
oxidative stress
phototoxicity
retinal degeneration
taurine
β-alanine treated
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
29 Dec 2021
29 Dec 2021
Historique:
received:
03
10
2021
revised:
15
12
2021
accepted:
22
12
2021
entrez:
11
1
2022
pubmed:
12
1
2022
medline:
4
2
2022
Statut:
epublish
Résumé
We investigate glial cell activation and oxidative stress induced by taurine deficiency secondary to β-alanine administration and light exposure. Two months old Sprague-Dawley rats were divided into a control group and three experimental groups that were treated with 3% β-alanine in drinking water (taurine depleted) for two months, light exposed or both. Retinal and external thickness were measured in vivo at baseline and pre-processing with Spectral-Domain Optical Coherence Tomography (SD-OCT). Retinal cryostat cross sections were immunodetected with antibodies against various antigens to investigate microglial and macroglial cell reaction, photoreceptor outer segments, synaptic connections and oxidative stress. Taurine depletion caused a decrease in retinal thickness, shortening of photoreceptor outer segments, microglial cell activation, oxidative stress in the outer and inner nuclear layers and the ganglion cell layer and synaptic loss. These events were also observed in light exposed animals, which in addition showed photoreceptor death and macroglial cell reactivity. Light exposure under taurine depletion further increased glial cell reaction and oxidative stress. Finally, the retinal pigment epithelial cells were Fluorogold labeled and whole mounted, and we document that taurine depletion impairs their phagocytic capacity. We conclude that taurine depletion causes cell damage to various retinal layers including retinal pigment epithelial cells, photoreceptors and retinal ganglion cells, and increases the susceptibility of the photoreceptor outer segments to light damage. Thus, beta-alanine supplements should be used with caution.
Identifiants
pubmed: 35008772
pii: ijms23010346
doi: 10.3390/ijms23010346
pmc: PMC8745531
pii:
doi:
Substances chimiques
Glial Fibrillary Acidic Protein
0
beta-Alanine
11P2JDE17B
Taurine
1EQV5MLY3D
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Fundación Seneca
ID : 19881/GERM/15
Organisme : Instituto de Salud Carlos III
ID : PI19/00203
Organisme : Instituto de Salud Carlos III
ID : SAF2015-67643
Organisme : Instituto de Salud Carlos III
ID : RD16/0008/0026
Organisme : Instituto de Salud Carlos III
ID : RED2018-102499-T
Organisme : Institut de la Vision
ID : ANR-18-IAHU-0001
Organisme : Institut de la Vision
ID : ANR-15-RHU-0001
Organisme : University of Murcia
ID : Fundación Robles Chillida
Références
Br J Sports Med. 2017 Apr;51(8):658-669
pubmed: 27797728
Front Pharmacol. 2021 Jan 18;11:601647
pubmed: 33584278
Invest Ophthalmol Vis Sci. 2018 Sep 4;59(11):4392-4403
pubmed: 30193320
Ann Neurol. 2009 Jan;65(1):98-107
pubmed: 19194884
Prog Retin Eye Res. 2020 Jan;74:100771
pubmed: 31356876
Int J Mol Sci. 2020 Sep 30;21(19):
pubmed: 33008136
J Neurosci Res. 1981;6(3):337-48
pubmed: 6271986
Acta Ophthalmol. 2014 Mar;92(2):149-57
pubmed: 23387307
Adv Nutr. 2019 May 1;10(3):452-463
pubmed: 30980076
Front Cell Neurosci. 2016 Apr 28;10:103
pubmed: 27199657
Invest Ophthalmol Vis Sci. 1977 Jul;16(7):673-8
pubmed: 873729
Sci Rep. 2020 Apr 29;10(1):7273
pubmed: 32350384
Vis Neurosci. 1989 Jul;3(1):33-8
pubmed: 2487089
J Neuroinflammation. 2020 Dec 14;17(1):375
pubmed: 33317557
Int J Mol Sci. 2020 Sep 28;21(19):
pubmed: 32998461
Brain Res. 1985 Mar 18;330(1):154-7
pubmed: 3986537
Adv Exp Med Biol. 2013;775:121-34
pubmed: 23392929
Sci Rep. 2016 Sep 14;6:33356
pubmed: 27624537
Amino Acids. 2012 Nov;43(5):1979-93
pubmed: 22476345
Br J Nutr. 2007 Oct;98(4):711-9
pubmed: 17466093
Br J Ophthalmol. 2014 Mar;98(3):396-401
pubmed: 24326325
Prog Retin Eye Res. 2014 Jul;41:44-63
pubmed: 24721186
Invest Ophthalmol Vis Sci. 2018 Mar 1;59(3):1396-1409
pubmed: 29625463
Ophthalmic Res. 1983;15(2):72-89
pubmed: 6136017
Cutan Ocul Toxicol. 2018 Sep;37(3):240-244
pubmed: 29417844
Neurochem Int. 2021 May;145:104987
pubmed: 33587954
PLoS One. 2014 Jul 16;9(7):e102392
pubmed: 25029531
Hum Mutat. 2018 Jul;39(7):887-913
pubmed: 29659094
J Comp Neurol. 2006 Sep 10;498(2):163-79
pubmed: 16856141
Front Immunol. 2019 Aug 20;10:1975
pubmed: 31481963
Clin Sci (Lond). 1986 Nov;71(5):559-64
pubmed: 3769404
Neural Regen Res. 2019 Jul;14(7):1186-1190
pubmed: 30804243
Adv Exp Med Biol. 2017;975 Pt 2:769-787
pubmed: 28849498
J Am Coll Nutr. 1986;5(2):127-35
pubmed: 3088082
Prog Retin Eye Res. 2014 Nov;43:17-75
pubmed: 25038518
Int J Mol Sci. 2019 Sep 19;20(18):
pubmed: 31546829
Exp Eye Res. 1988 Feb;46(2):229-38
pubmed: 3350067
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(8):3533-44
pubmed: 27379578
Exp Eye Res. 1995 Dec;61(6):731-41
pubmed: 8846845
Graefes Arch Clin Exp Ophthalmol. 2000 Dec;238(12):998-1001
pubmed: 11196364
Exp Eye Res. 2020 Oct;199:108167
pubmed: 32735798
Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):5824-35
pubmed: 21666244
Drug Des Devel Ther. 2019 Aug 07;13:2689-2702
pubmed: 31496648
Neural Dev. 2019 Dec 30;14(1):12
pubmed: 31888774
Exp Eye Res. 2010 Dec;91(6):800-10
pubmed: 20955700
Transl Vis Sci Technol. 2019 Dec 16;8(6):36
pubmed: 31890348
Exp Eye Res. 1992 Jul;55(1):47-52
pubmed: 1397129
Epilepsia. 2010 Oct;51(10):2175-89
pubmed: 20608959
Exp Eye Res. 2017 Aug;161:10-16
pubmed: 28552384
Biomed Res Int. 2016;2016:2954721
pubmed: 27294114
Mol Vis. 2011;17:1716-33
pubmed: 21738401
Neural Regen Res. 2018 Nov;13(11):1885-1886
pubmed: 30233058
Hum Mol Genet. 2000 Mar 1;9(4):645-51
pubmed: 10699188
Front Neuroanat. 2017 Mar 06;11:14
pubmed: 28321183
Exp Eye Res. 1988 Jan;46(1):13-20
pubmed: 3342832
Brain Res. 1995 Nov 6;698(1-2):1-14
pubmed: 8581466
Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4592-604
pubmed: 26200499
Prog Retin Eye Res. 2016 Mar;51:1-40
pubmed: 26113209
Exp Eye Res. 2021 Feb;203:108391
pubmed: 33307075
Neurochem Res. 2004 Jan;29(1):151-60
pubmed: 14992274
Invest Ophthalmol Vis Sci. 2020 Aug 3;61(10):1
pubmed: 32744596
Sci Rep. 2020 Mar 17;10(1):4890
pubmed: 32184450
Sci Rep. 2018 Jan 31;8(1):1968
pubmed: 29386551
Proc Natl Acad Sci U S A. 2020 Oct 6;117(40):24867-24875
pubmed: 32958638
Neuroscience. 2015 Feb 12;286:60-78
pubmed: 25433236
Brain Res. 1992 Aug 14;588(1):21-8
pubmed: 1393569
Cell Rep. 2020 Dec 15;33(11):108507
pubmed: 33326790
Mol Vis. 2012;18:2673-86
pubmed: 23170060
Neuropediatrics. 2016 Aug;47(4):263-7
pubmed: 27104484
Mol Cell Neurosci. 2010 Apr;43(4):414-21
pubmed: 20132888
Eur J Neurosci. 1999 Oct;11(10):3683-93
pubmed: 10564375
Amino Acids. 2007 Jan;32(1):115-9
pubmed: 16622601
PLoS One. 2018 Mar 15;13(3):e0194218
pubmed: 29543853
Exp Eye Res. 2019 Nov;188:107781
pubmed: 31473259
Neurology. 2004 May 25;62(10):1668-81
pubmed: 15159460
Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4692-703
pubmed: 27607415
Biomol Ther (Seoul). 2018 May 1;26(3):225-241
pubmed: 29631391
Cell Physiol Biochem. 2016;40(5):831-846
pubmed: 27941319
Invest Ophthalmol Vis Sci. 2020 Mar 9;61(3):47
pubmed: 32232352
Curr Eye Res. 2020 Jan;45(1):52-63
pubmed: 31404506
Exp Eye Res. 1987 Mar;44(3):331-46
pubmed: 3595755
J Comp Neurol. 2007 Apr 20;501(6):866-78
pubmed: 17311318
CNS Neurosci Ther. 2021 Apr;27(4):403-412
pubmed: 33621439
Cell Death Dis. 2018 Mar 22;9(4):435
pubmed: 29568078
Vision Res. 2004;44(17):2091-100
pubmed: 15149840
Hum Mol Genet. 2020 Mar 13;29(4):618-623
pubmed: 31903486
FASEB J. 2019 Oct;33(10):11507-11527
pubmed: 31345061